DFID to invest £138 million over 5 years into 9 public-private partnerships

  The U.K. Department for International Development (DFID) said it is investing £138 million over the next 5 years into 9 public-private partnerships “to support the development of innovative new drugs, vaccines, insecticides, diagnostic tools and microbicides… The partnerships will bring together experts in the field while also sharing the costs and risks across partners.” The nine Product Development Partnerships (PDPs) receiving support include [Editor’s bolded text]:

:: Drugs for Neglected Diseases initiative (DNDi): new drugs for sleeping sickness, skin sores, river blindness and other lymphatic diseases spread by parasites and mosquitoes

:: Medicines for Malaria Venture (MMV): new drugs for malaria, with a focus on treating malaria in pregnancy and the relapsing form of malaria

:: Innovative Vector Control Consortium (IVCC): new insecticides to control insects that carry malaria and some of the neglected tropical diseases

:: Foundation for Innovative New Diagnostics (FIND): new diagnostic tests for TB, malaria and sleeping sickness

:: TB Alliance: new drugs for people with TB and for those also infected with HIV

:: Aeras: development of new vaccines to prevent TB infection

:: New Products for Diarrhoea and Malaria (PATH): developing new drugs, diagnostics and vaccines for diarrhoeal disease and diagnostics for malaria

::: International AIDS Vaccine Initiative (IAVI): support for the development of new AIDS vaccines

::International Partnership for Microbicides (IPM): support for the development of women-controlled HIV prevention technologies.